CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer
Article in Cancer Letters (April 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Cancer Letters (April 2024)
Preprint in bioRxiv (November 2023)